Anna Bauer‐Mehren

3.5k total citations · 1 hit paper
31 papers, 2.4k citations indexed

About

Anna Bauer‐Mehren is a scholar working on Molecular Biology, Computational Theory and Mathematics and Toxicology. According to data from OpenAlex, Anna Bauer‐Mehren has authored 31 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 8 papers in Computational Theory and Mathematics and 7 papers in Toxicology. Recurrent topics in Anna Bauer‐Mehren's work include Biomedical Text Mining and Ontologies (10 papers), Bioinformatics and Genomic Networks (9 papers) and Computational Drug Discovery Methods (8 papers). Anna Bauer‐Mehren is often cited by papers focused on Biomedical Text Mining and Ontologies (10 papers), Bioinformatics and Genomic Networks (9 papers) and Computational Drug Discovery Methods (8 papers). Anna Bauer‐Mehren collaborates with scholars based in United States, Spain and Germany. Anna Bauer‐Mehren's co-authors include Ferrán Sanz, Laura I. Furlong, Paea LePendu, Nigam H. Shah, Janet Piñero, Martín Baron, Álex Bravo, Núria Queralt-Rosiñach, Jordi Deu-Pons and Srinivasan Iyer and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Bioinformatics.

In The Last Decade

Anna Bauer‐Mehren

31 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

DisGeNET: a discovery platform for the dynamical exploration of human diseases and their genes

2015 785 citations Janet Piñero, Núria Queralt-Rosiñach et al. Database profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anna Bauer‐Mehren United States	18	1.2k	465	343	194	193	31	2.4k
Lang Li United States	23	1.2k 1.0×	521 1.1×	105 0.3×	98 0.5×	202 1.0×	114	2.2k
Lang Li United States	39	2.0k 1.7×	314 0.7×	113 0.3×	119 0.6×	599 3.1×	158	5.1k
Stephen Harris United States	24	893 0.7×	134 0.3×	122 0.4×	57 0.3×	108 0.6×	71	2.5k
Russell A. Wilke United States	34	1.2k 1.0×	308 0.7×	99 0.3×	189 1.0×	868 4.5×	93	4.5k
Gideon Y. Stein Israel	21	938 0.8×	657 1.4×	46 0.1×	120 0.6×	62 0.3×	58	2.0k
Herbert Chase United States	24	830 0.7×	299 0.6×	432 1.3×	293 1.5×	55 0.3×	56	1.8k
Karthik Venkatakrishnan United States	42	1.7k 1.4×	620 1.3×	116 0.3×	26 0.1×	115 0.6×	199	6.6k
Andrea Jorgensen United Kingdom	32	468 0.4×	164 0.4×	83 0.2×	60 0.3×	345 1.8×	107	3.7k
Jeffery L. Painter United States	10	525 0.4×	146 0.3×	147 0.4×	54 0.3×	394 2.0×	28	1.3k
Sara K. Quinney United States	23	509 0.4×	341 0.7×	163 0.5×	38 0.2×	41 0.2×	102	1.9k

Countries citing papers authored by Anna Bauer‐Mehren

Since Specialization

Citations

This map shows the geographic impact of Anna Bauer‐Mehren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Bauer‐Mehren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Bauer‐Mehren more than expected).

Fields of papers citing papers by Anna Bauer‐Mehren

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Bauer‐Mehren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Bauer‐Mehren. The network helps show where Anna Bauer‐Mehren may publish in the future.

Co-authorship network of co-authors of Anna Bauer‐Mehren

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Bauer‐Mehren. A scholar is included among the top collaborators of Anna Bauer‐Mehren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Bauer‐Mehren. Anna Bauer‐Mehren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Roller, Andreas, et al.. (2023). Matching byOSPrognostic Score to Construct External Controls in Lung Cancer Clinical Trials. Clinical Pharmacology & Therapeutics. 115(2). 333–341. 1 indexed citations

Becker, Tim, et al.. (2021). Artificial Intelligence for Prognostic Scores in Oncology: a Benchmarking Study. Frontiers in Artificial Intelligence. 4. 625573–625573. 14 indexed citations

Nahkuri, Satu, et al.. (2021). Prior fluid and electrolyte imbalance is associated with COVID-19 mortality. SHILAP Revista de lepidopterología. 1(1). 51–51. 11 indexed citations

Becker, Tim, Janick Weberpals, W. Venus So, et al.. (2020). An enhanced prognostic score for overall survival of patients with cancer derived from a large real-world cohort. Annals of Oncology. 31(11). 1561–1568. 18 indexed citations

Piñero, Janet, Núria Queralt-Rosiñach, Álex Bravo, et al.. (2015). DisGeNET: a discovery platform for the dynamical exploration of human diseases and their genes. Database. 2015(0). bav028–bav028. 785 indexed citations breakdown →

Shah, Nigam H., Paea LePendu, Anna Bauer‐Mehren, et al.. (2015). Proton Pump Inhibitor Usage and the Risk of Myocardial Infarction in the General Population. PLoS ONE. 10(6). e0124653–e0124653. 240 indexed citations

Cole, Tyler S., Jennifer Frankovich, Srinivasan Iyer, et al.. (2013). Profiling risk factors for chronic uveitis in juvenile idiopathic arthritis: a new model for EHR-based research. Pediatric Rheumatology. 11(1). 45–45. 30 indexed citations

LePendu, Paea, Srinivasan Iyer, Anna Bauer‐Mehren, et al.. (2013). Pharmacovigilance Using Clinical Notes. Clinical Pharmacology & Therapeutics. 93(6). 547–555. 124 indexed citations

Leeper, Nicholas J., Anna Bauer‐Mehren, Srinivasan Iyer, et al.. (2013). Practice-Based Evidence: Profiling the Safety of Cilostazol by Text-Mining of Clinical Notes. PLoS ONE. 8(5). e63499–e63499. 60 indexed citations

10.

Iyer, Srinivasan, Rave Harpaz, Paea LePendu, Anna Bauer‐Mehren, & Nigam H. Shah. (2013). Mining clinical text for signals of adverse drug-drug interactions. Journal of the American Medical Informatics Association. 21(2). 353–362. 125 indexed citations

11.

Lopes, Pedro, David Campos, Laura I. Furlong, et al.. (2013). Gathering and Exploring Scientific Knowledge in Pharmacovigilance. PLoS ONE. 8(12). e83016–e83016. 17 indexed citations

12.

Harpaz, Rave, William DuMouchel, Paea LePendu, et al.. (2013). Performance of Pharmacovigilance Signal-Detection Algorithms for the FDA Adverse Event Reporting System. Clinical Pharmacology & Therapeutics. 93(6). 539–546. 240 indexed citations

13.

LePendu, Paea, Anna Bauer‐Mehren, Srinivasan Iyer, & Nigam H. Shah. (2012). Abstract 15727: Analyzing Unstructured Clinical Notes for Phase IV Drug Safety Surveillance. Circulation. 126. 1 indexed citations

14.

Bauer‐Mehren, Anna, Erik M. van Mulligen, Paul Avillach, et al.. (2012). Automatic Filtering and Substantiation of Drug Safety Signals. PLoS Computational Biology. 8(4). e1002457–e1002457. 28 indexed citations

15.

Oliveira, José Luís, Pedro Lopes, David Campos, et al.. (2012). The EU‐ADR Web Platform: delivering advanced pharmacovigilance tools. Pharmacoepidemiology and Drug Safety. 22(5). 459–467. 33 indexed citations

16.

Bauer‐Mehren, Anna, Erik M. van Mulligen, Paul Avillach, et al.. (2012). Correction: Automatic Filtering and Substantiation of Drug Safety Signals. PLoS Computational Biology. 8(5). 1 indexed citations

17.

Bauer‐Mehren, Anna, Markus Bundschus, Michael Rautschka, et al.. (2011). Gene-Disease Network Analysis Reveals Functional Modules in Mendelian, Complex and Environmental Diseases. PLoS ONE. 6(6). e20284–e20284. 135 indexed citations

18.

Risselada, Roelof, Hester F. Lingsma, Anna Bauer‐Mehren, et al.. (2010). Prediction of 60 day case-fatality after aneurysmal subarachnoid haemorrhage: results from the International Subarachnoid Aneurysm Trial (ISAT). European Journal of Epidemiology. 25(4). 261–266. 60 indexed citations

19.

Bauer‐Mehren, Anna, Laura I. Furlong, Michael Rautschka, & Ferrán Sanz. (2009). From SNPs to pathways: integration of functional effect of sequence variations on models of cell signalling pathways. BMC Bioinformatics. 10(S8). S6–S6. 20 indexed citations

20.

Selent, Jana, Anna Bauer‐Mehren, Laura López, et al.. (2009). A Novel Multilevel Statistical Method for the Study of the Relationships between Multireceptorial Binding Affinity Profiles and In Vivo Endpoints. Molecular Pharmacology. 77(2). 149–158. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact